Clearside Biomedical Inc. (NASDAQ: CLSD)
$1.22
-0.0250 ( -2.02% ) 185.5K
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Market Data
Open
$1.22
Previous close
$1.24
Volume
185.5K
Market cap
$91.17M
Day range
$1.19 - $1.25
52 week range
$0.65 - $2.12
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 20, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
10-q | Quarterly Reports | 66 | May 10, 2024 |
8-k | 8K-related | 13 | May 09, 2024 |
def | Proxies and info statements | 6 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 19, 2024 |
8-k | 8K-related | 13 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 16, 2024 |
3 | Insider transactions | 2 | Apr 16, 2024 |